Clinical Trial Update: Severe CAV MRI in Heart Transplant Recipient

View source ↗

Summary

A clinical trial evaluating MRI for severe cardiac allograft vasculopathy in heart transplant recipients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Allograft Vasculopathy

Snippet

Sponsor: University of Minnesota | Conditions: Cardiac Allograft Vasculopathy | Status: WITHDRAWN